Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Entelos announces expanded research with Pfizer
December 2007
SHARING OPTIONS:

FOSTER CITY, Calif.-Entelos Inc. announced that Pfizer Inc. signed an agreement with Entelos to expand and continue research using the Entelos Cardiovascular PhysioLab platform. The expanded research will focus on identifying biomarkers and interpretation of clinical study data. Financial terms are not disclosed. The Entelos Cardiovascular PhysioLab platform is a predictive computer model that simulates patients and drug effects, and represents key biological mechanisms and disease processes that can help to explain the underlying causes of heart attacks, strokes and other serious cardiovascular conditions in multiple patient types.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.